Although we demonstrated that DEFA3 inhibits proliferation and migration of CT26 cells in vitro, and linked MMP11/MYL9 expression to advanced CRC in human datasets, we did not test the functional impact of these genes in living tumor models. Here, MYL9 is linked to neoplasm.